Your search for pilot research returned 278 results.
Selected filters: Scientists
Displaying 101 to 110 of 278 records
Sort by: Page:  << Prev 891011121314Next >>
  • Amir Iravani, MD, Receives SNMMI Mars Shot Fund Award – Jun 7, 2023
    SNMMI is excited to announce that Amir Iravani, MD, has been selected as the recipient of a $1,000,000 SNMMI Mars Shot Fund Grant.
  • Craig Levin, PhD, Receives SNMMI Mars Shot Fund Award – Jun 7, 2023
    SNMMI is excited to announce that Craig Levin, PhD, has been selected as the recipient of a $500,000 grant from the 2023 Mars Shot Fund.
  • Julie Sutcliffe, PhD, Receives SNMMI Mars Shot Fund Award – Jun 7, 2023
    SNMMI is excited to announce that Julie Sutcliffe, PhD, has been selected as the recipient of a $500,000 grant from the 2023 Mars Shot Fund.
  • Randy Yeh, MD, Receives SNMMI Mars Shot Fund Award – Jun 7, 2023
    SNMMI is excited to announce that Randy Yeh, MD, has been selected as the recipient of a $500,000 grant from the 2023 Mars Shot Research Fund.
  • Ellison, Scott and Sanford Receive SNMMI Mars Shot Fund Award – Jun 7, 2023
    SNMMI is excited to announce Paul Ellison, PhD, Peter J. H. Scott, PhD, and Melanie S. Sanford, PhD, have been selected as the recipients of a $500,000 grant from the 2023 Mars Shot Fund.
  • Academic Council – May 31, 2023
    The Academic Council is composed of faculty members of nuclear medicine departments, divisions, or sections in accredited medical schools, those in approved nuclear medicine residency programs, or in accredited technologist training programs. However, any individual interested in education is welcome to join. The Academic Council is dedicated to the scientific interchange of ideas among SNMMI members who have an interest in training and education of undergraduates and graduates in Nuclear Medicine (which includes general Nuclear Medicine, Cardiovascular Nuclear Medicine, PET/CT imaging and Molecular Imaging).The overall mission of the Academic Council is to: promote medical education, research and patient care related to Nuclear Medicine, provide to membership expertise in the training and education of undergraduates and graduates in Nuclear Medicine, including in mentoring and leadership, provide a forum for members for discussion of issues and problems of mutual interest and concern within the Nuclear Medicine community, as well as an informal exchange of ideas and programs, provide outreach to other professionals and organizations, nurture new membership into the society, serve as a resource to Young Professionals in career development, and serve as a resource to SNMMI leadership. Within the Council there is a subgroup of Program Directors/Associate Program Directors of Nuclear Medicine residency programs (the Nuclear Medicine Program Directors Association, NMPDA). The Academic Council is an advocate for Nuclear Medicine education and training to organized Radiology and Nuclear Medicine, as well as providing an avenue of communication for Program Directors and Coordinators to accrediting bodies, certification boards, other specialty societies, and government agencies.
  • Make ConnectionsUnlock the Power of Networking – May 17, 2023
    Are you looking to take your career to the next level? Do you want to make valuable connections that can help you achieve your professional goals?
  • Celebrate Clinical Trials Day with the SNMMI Clinical Trials Network! – May 15, 2023
    The SNMMI Clinical Trials Network (CTN) is celebrating Clinical Trials Day on Saturday, May 20!
  • Amino Acid PET Successfully Differentiates Recurrent Brain Metastases, Reducing Invasive Procedures and Overtreatment – May 12, 2023
    A new meta-analysis indicates that amino acid PET can accurately differentiate recurrent or progressive brain metastases from treatment-related changes, potentially reducing overtreatment, according to research published in May JNM.
  • New Research: FAPI PET Imaging Superior for Diagnosing Multiple Types of Cancer, with Potential for Targeted Treatment – May 1, 2023
    Two articles in the May issue of JNM illustrate the promise of the novel FAPI radiotracer. Results from the largest study of patients undergoing 68Ga-FAPI PET demonstrate the superiority of 68Ga-FAPI over standard 18F-FDG PET in evaluating multiple types of cancer. In a separate study, a newly designed FAPI-targeted treatment was found to suppress tumor growth in several common cancers in a preclinical setting. These advances have strong potential to provide more precise staging and management for cancer patients.
Displaying 101 to 110 of 278 records
Page:  << Prev 891011121314Next >>